Cargando…
Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients - an analysis of the DiaRegis registry
BACKGROUND: We aimed to identify predictors of anamnestic hypoglycaemia in type-2 diabetic patients on oral mono- or dual oral combination antidiabetic pharmacotherapy. METHODS: DiaRegis is a prospective registry in type-2 diabetic patients in primary care. Odds ratios (OR) with 95% confidence inter...
Autores principales: | Tschöpe, Diethelm, Bramlage, Peter, Binz, Christiane, Krekler, Michael, Plate, Tanja, Deeg, Evelin, Gitt, Anselm K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162488/ https://www.ncbi.nlm.nih.gov/pubmed/21756359 http://dx.doi.org/10.1186/1475-2840-10-66 |
Ejemplares similares
-
Incidence and predictors of hypoglycaemia in type 2 diabetes – an analysis of the prospective DiaRegis registry
por: Tschöpe, Diethelm, et al.
Publicado: (2012) -
Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline
por: Bramlage, Peter, et al.
Publicado: (2010) -
Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registry
por: Wasem, Jürgen, et al.
Publicado: (2013) -
Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up
por: Bramlage, Peter, et al.
Publicado: (2014) -
Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia
por: Bramlage, Peter, et al.
Publicado: (2012)